Henan Taloph Pharmaceutical Stock Co Ltd - Class A

SHSE:600222 (China)   Class A
Â¥ 4.28 (+0.71%) Jun 21
39.27
P/B:
1.55
Market Cap:
Â¥ 2.46B ($ 338.28M)
Enterprise V:
Â¥ 2.96B ($ 407.65M)
Volume:
5.59M
Avg Vol (2M):
15.03M
Trade In:
Volume:
5.59M
Avg Vol (2M):
15.03M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Henan Taloph Pharmaceutical Stock Co Ltd ( SHSE:600222 ) from 1999 to Jun 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Henan Taloph Pharmaceutical Stock stock (SHSE:600222) PE ratio as of Jun 21 2024 is 39.27. More Details

Henan Taloph Pharmaceutical Stock Co Ltd (SHSE:600222) PE Ratio (TTM) Chart

To

Henan Taloph Pharmaceutical Stock Co Ltd (SHSE:600222) PE Ratio (TTM) Historical Data

Total 1214
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Henan Taloph Pharmaceutical Stock PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-21 39.3 2024-04-17 45.6
2024-06-20 39.0 2024-04-16 43.6
2024-06-19 39.9 2024-04-15 48.4
2024-06-18 40.1 2024-04-12 51.9
2024-06-17 39.7 2024-04-11 51.3
2024-06-14 40.3 2024-04-10 49.9
2024-06-13 40.5 2024-04-09 48.4
2024-06-12 41.4 2024-04-08 47.4
2024-06-11 40.6 2024-04-05 48.7
2024-06-07 41.0 2024-04-03 48.7
2024-06-06 38.8 2024-04-02 48.7
2024-06-05 40.9 2024-04-01 49.3
2024-06-04 41.6 2024-03-29 48.4
2024-06-03 42.0 2024-03-28 48.3
2024-05-31 43.7 2024-03-27 66.7
2024-05-30 43.2 2024-03-26 66.9
2024-05-29 43.8 2024-03-25 66.5
2024-05-28 43.9 2024-03-22 68.8
2024-05-27 44.8 2024-03-21 70.6
2024-05-24 44.9 2024-03-20 69.4
2024-05-23 45.0 2024-03-19 68.2
2024-05-22 46.2 2024-03-18 67.7
2024-05-21 46.5 2024-03-15 66.5
2024-05-20 47.6 2024-03-14 66.3
2024-05-17 47.3 2024-03-13 66.0
2024-05-16 47.4 2024-03-12 66.3
2024-05-15 47.6 2024-03-11 64.5
2024-05-14 48.4 2024-03-08 63.3
2024-05-13 48.5 2024-03-07 62.7
2024-05-10 49.0 2024-03-06 63.7
2024-05-09 49.4 2024-03-05 63.6
2024-05-08 48.4 2024-03-04 65.9
2024-05-07 47.9 2024-03-01 63.2
2024-05-06 48.1 2024-02-29 62.7
2024-05-03 46.7 2024-02-28 61.4
2024-05-02 46.7 2024-02-27 65.3
2024-04-30 46.7 2024-02-26 64.2
2024-04-29 46.6 2024-02-23 61.9
2024-04-26 46.0 2024-02-22 60.4
2024-04-25 46.3 2024-02-21 59.0
2024-04-24 45.4 2024-02-20 59.2
2024-04-23 46.4 2024-02-19 57.6
2024-04-22 45.1 2024-02-16 54.1
2024-04-19 43.9 2024-02-09 54.1
2024-04-18 43.4 2024-02-08 54.1

Henan Taloph Pharmaceutical Stock Co Ltd (SHSE:600222) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Henan Taloph Pharmaceutical Stock Co Ltd is a Chinese company engaged in the manufacture of Western and Chinese medicine products, including oral liquids, tablets, capsules, and bulk drugs. Geographically, the business activities are functioned through China region.